ERIS Eris Lifesciences Ltd
Healthcare
LTP
1,163.7
CHG · %
-12.5 (-1.06%)
VOL · TODAY
29.74K
PREV CLOSE
1,176.2
Today's range1,160.1 · 1,182.4
1,163.7
52-week range1,069 · 1,740
1,163.7
Loading candles…
Eris Lifesciences Ltd operates in the pharmaceutical industry in India, focusing on the manufacture and marketing of domestic pharmaceutical formulations. The company’s portfolio includes products in cardiology, diabetes, gastroenterology, dermatology, as well as medical aesthetics and injectables. Its business model centers on a pure-play domestic formulations strategy supported by a field force that engages with super-specialist and specialist doctors. Eris Lifesciences has established a strong market position in the chronic segment, which constitutes a significant portion of its revenue. There is no publicly available information regarding its incorporation year, founders, key management, subsidiaries, or stock exchange listings.
ERIS is not part of any active scan today.
This page is a live market overview for Eris Lifesciences Limited (ERIS) on the BSE. As a listed security, Eris Lifesciences Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ERIS before placing trades on tick2trade.
As of the latest feed, ERIS last traded at ₹1,163.7 on BSE, down ₹12.5 (1.06%) from the previous close of ₹1,176.2. Today's session range is ₹1,160.1 – ₹1,182.4, against a 52-week band of ₹1,069 – ₹1,740. Traded volume today stands at 29.74K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ERIS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ERIS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Eris Lifesciences Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ERIS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ERIS option chain page linked from this overview.
// similar in healthcare326 total